TS1-ASO

N/A

Report date: 2026/05/25 13:59:01

NME

Base Information

Drug NameTS1-ASO

Drug Alias NameAntisense oligonucleotide targeting CACNA1C exon 8A/8 splicing (Stanford University)TS1-ASO

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusN/A

Highest Status in ChinaN/A

Originator CompaniesStanford University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A